4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-031241
EVP, COO, Head of Commercial sold 14,869 shares at $22.50 ($334,553)
- EVP, COO, Head of Commercial acquired 29,738 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, Head of Commercial | 2023-05-17 | Option exercise | +14,869 | 24,356 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-05-17 | Option exercise | +14,869 | 39,225 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-05-17 | Sale | −14,869 | $22.50 | $334,553 | 24,356 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-05-17 | Option exercise · Restricted Stock Units | −14,869 | 24,782 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-05-17 | Option exercise · Restricted Stock Units | −14,869 | 24,782 | D | ||
| Open-market sales · 14,869 sh · avg $22.50 · $334,553 | |||||||
Loading xslF345X04/doc4.xml…